PENTA 5

Evolution of drug resistance in antiretroviral therapy-naïve children in PENTA 5

18 Apr, 2001

Authors: Loveday. C., Walker. A.S., Gibb. D.M., on behalf of the PENTA virology Group Published in:  Fifth International Workshop on HIV Drug Resistance and Treatment Strategies, 2001, Scottsdale, USA. Abstract …
Read More

T cell repopulation in HIV infected children on highly active anti-retroviral therapy (HAART)

18 Apr, 2001

Authors: King D J.S., Gotch F M., Larsson-Sciard E. Published in: Clin Exp Immunol.2001;125(3):447-454 Abstract In this pilot study, we address the nature of the re-population of the T-cell compartment…
Read More

Reconstitution of the T-cell Pool in Treated, HIV-infected Children

18 Apr, 2000

Authors: King D, Gibb DM, Gotch F, Larsson-Sciard E. Published in: 7th Conference on Retroviruses and Opportunistic Infections, January 30th- February 2nd, 2000, Abstract 322., San Francisco. Abstract 322
Read More

Immune repopulation after HAART in previously untreated HIV-1 infected children

18 Apr, 2000

Authors: Gibb DM, Newberry A, Klein N, de Rossi A, Grosch-Wörner I, Babiker A Published in: Lancet.2000; 355: 1331-2 Abstract In 25 vertically HIV-infected children receiving highly-active antiretroviral therapy, a…
Read More

A randomised trial evaluating three NRTI regimens with and without Nelfinavir in HIV-infected children: 48 week follow-up from the PENTA 5 trial

18 Apr, 2000

Authors: Gibb. D. M. for the PENTA 5 Executive and the PENTA Steering Committee. Published in: Oral presentation at 5th International Congress on Drug Therapy in HIV Infection, Glasgow 22-26 October 2000 also published…
Read More

Drug resistance in a trial of nucleoside analogue and protease inhibitor therapy in children (PENTA 5)

18 Apr, 2000

Authors: Kaye S. on behalf of the PENTA Virology Committee. Published in: 5th International Congress on Drug Therapy in HIV Infection, October 22nd-26th 2000, Glasgow. P_308.
Read More
1 2